Verathon is a U.S.-based company specializing in the manufacturing of medical devices and equipment, particularly in the field of bronchoscopes. Founded in 1984, the company has developed a range of products aimed at enhancing clinical procedures. One of its notable offerings is the BFlex™ series of single-use bronchoscopes, with the BFlex 2 launched in 2023. A recent research report evaluates the performance of the BFlex 2 in comparison to other commercially available bronchoscopes, including the Ambu® aScope™ and Olympus BF-1TH190. The study indicates that the BFlex 2 demonstrates superior suction strength and requires lower insertion force when advancing tools, highlighting its potential advantages in clinical settings. Verathon operates with a workforce of between 501 and 1,000 employees and reported revenue of approximately $125 million. The company continues to focus on innovation within the medical device sector, as evidenced by its ongoing enhancements to its product offerings.